Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Solutions at GoodRx
Laura explores the structural hurdles that slow time-to-therapy and outlines practical ways stakeholders can streamline the path from prescription intent to treatment initiation.
To learn more, book a meeting with GoodRx.
Read on for Laura’s insights.
Read more »
Source: Post feed
